• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Genomics And Proteomics Reagents, Research Kits And Analytical Instruments Market - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019 Product Image

Genomics And Proteomics Reagents, Research Kits And Analytical Instruments Market - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019

  • ID: 2639689
  • August 2013
  • Region: Global
  • 115 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Affymetrix
  • Bio-Rad
  • Danaher Corporation
  • Merck Millipore
  • Perkinelmer
  • Shimadzu Biotech
  • MORE

'Genomics And Proteomics Reagents, Research Kits And Analytical Instruments Market (Sample Preparation, Electrophoresis, BioChips And Microarrays, Chromatography, Mass Spectrometry, Thermal Cyclers, Next-Gen Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019'

Genomics and proteomics have greatly increased the volume and quality of information with regards to several lesser known genetic diseases and as such have expedited the cure for many illnesses. This market report encompasses the various technologies that account for genomics and proteomics research by various end users such as drug discovery and development, life-science research such as disease identification and diagnostics. The stakeholders for this study include market players who manufacture reagents and research kits, analytical tools and other products used in genomics and proteomics research.

The market accounts for commercialized ready-to-use research kits to carry out various processes such as isolation, purification, labeling probes, electrophoresis, chromatography, polymerase chain reactions. The study also accounts for specialized analytical tools for proteomics READ MORE >

FEATURED COMPANIES

  • Affymetrix
  • Bio-Rad
  • Danaher Corporation
  • Merck Millipore
  • Perkinelmer
  • Shimadzu Biotech
  • MORE

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation: Genomics & Proteomics
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.4 Assumptions And Stipulations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Genomics and Proteomics Market

Chapter 3 Global Genomics and Proteomics Market Overview
3.1 Genomics and Proteomics Industry Overview and Milestones
3.2 Applications of Genomics and Proteomics Technologies
3.2.1 Agriculture and Animal Husbandry
3.2.2 Drug Discovery
3.2.3 Forensics
3.2.4 Proteogenomics Research
3.2.5 Disease Identification, Diagnostics and Control
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Drug Discovery and Disease Identification a Strong Driver
3.3.1.2 Increased Investment in Healthcare and Medical Research by Developing Countries
3.3.1.3 Software and Service Sector in Genomics and Proteomics is Booming
3.3.2 Restraints
3.3.2.1 Low Adoption and Penetration in Developing Countries due to Cost of Technology
3.3.2.2 Highly Fragmented Market may Increase Volume but is Expected to Reduce in Terms of Revenue
3.3.3 Opportunities
3.3.3.1 Collaboration for Research with Research Facilities in Developing Countries
3.4 Market Attractiveness for Genomics and Proteomics Market, by Geography
3.5 Porters Five Forces Analysis for Genomics and Proteomics Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat from Substitutes
3.5.4 Threat from New Entrants
3.5.5 Degree of Competitive Rivalry

Chapter 4 Global Genomics and Proteomics Reagents and Research Kits Market
4.1 Sample Preparation Kits Market
4.1.1 Global Sample Preparation Kits Market, By Segments, 2011 - 2019 (USD Million)
4.1.2 Prepackaged Sample Preparation for Polymerase Chain Reaction
4.1.3 Prepackaged Sample Preparation for Mass Spectrometry
4.1.4 Prepackaged Sample Preparation for Chromatography
4.1.5 Prepackaged Sample Preparation for Electrophoresis
4.2 Purification Reagent Kits
4.2.1 Global Purification Reagent Kits Market, by Segments, 2011 - 2019 (USD Million)
4.2.2 Global Purification Kits Market, by Geography, 2011 - 2019 (USD Million)
4.3 Electrophoresis Kits
4.3.1 Global Electrophoresis Kits Market, by Geography, 2011 - 2019 (USD Million)
4.3.2 Capillary Electrophoresis
4.3.3 Gel Electrophoresis
4.4 Biochips and Microarrays
4.4.1 Global Biochips and Microarrays Market, by Geography, 2011 - 2019 (USD Million)
4.4.2 DNA Microarrays
4.4.3 Protein and Peptide Microarrays

Chapter 5 Global Genomics and Proteomics Analytical Tools Market, by Technologies, 2011 - 2019 (USD Million)
5.1 Chromatography
5.1.1 Global Chromatography Market, by Types, 2011 - 2019 (USD Million)
5.1.2 Global Chromatography Market, by Geography, 2011 - 2019 (USD Million)
5.1.3 Gas Chromatography
5.1.4 Liquid Chromatography
5.1.4.1 High Performance Liquid Chromatography
5.1.4.2 Ultra High Performance Chromatography
5.2 Mass Spectrometry
5.2.1 Global Mass Spectrometry Market, by Analyzers, 2011 - 2019 (USD Million)
5.2.2 Tandem Mass Spectrometry
5.2.3 Quadrupole Mass Spectrometry
5.2.4 Fourier Transform Mass Spectrometry
5.2.5 TOF Mass Spectrometry
5.2.6 Other Mass Spectrometry Analyzers
5.3 Thermal Cyclers
5.3.1 Global Thermal Cyclers Market, by Types, 2011 - 2019 (USD Million)
5.3.2 Digital PCR Thermal Cyclers
5.3.3 Conventional or Traditional Thermal Cyclers
5.3.4 Real-Time PCR Thermal Cyclers
5.4 Next Generation Sequencing
5.4.1 Global Next Generation Sequencing Market, by Geography, 2011 - 2019 (USD Million)

Chapter 6 Genomics and Proteomics Market, by Geography, 2011 - 2019 (USD Million)
6.1 Introduction
6.1.1 Global Genomics and Proteomics Market, by Geography, 2011 - 2019 (USD Million)
6.2 North America
6.2.1 North America Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
6.3 Europe
6.3.1 Europe Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
6.5 Rest of the World
6.5.1 Row Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)

Chapter 7 Market Share Analysis of Key Players, 2012
7.1 Market Share Analysis of Key Players, 2012 (%)

Chapter 8 Company Profiles
8.1 Affymetrix
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Agilent Technologies
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Becton Dickinson & Company
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Bio-Rad
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Bruker Corporation
8.5.1 Business Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Danaher Corporation
8.6.1 Business Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.7 Illumina, Inc.
8.7.1 Business Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Life Technologies Corporation
8.8.1 Business Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Merck Millipore
8.9.1 Business Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Myriad Genetics, Inc.
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Portfolio
8.10.4 Business Strategies
8.10.5 Recent Developments
8.11 Perkinelmer
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Qiagen
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.5 Recent Developments
8.13 Shimadzu Biotech
8.13.1 Company Overview
8.13.2 Financial Overview
8.13.3 Product Portfolio
8.13.4 Business Strategies
8.13.5 Recent Developments
8.14 Sigma Aldrich Corporation
8.14.1 Company Overview
8.14.2 Financial Overview
8.14.3 Product Portfolio
8.14.4 Business Strategies
8.14.5 Recent Developments
8.15 Thermo Fisher Scientific
8.15.1 Company Overview
8.15.2 Financial Overview
8.15.3 Product Portfolio
8.15.4 Business Strategies

List of Figures

FIG. 1 Genomics & Proteomics Market Segmentation
FIG. 2 Global Genomics and Proteomics Market, by Segments, 2012 (USD Million)
FIG. 3 Market Attractiveness for Genomics and Proteomics Market, by Geography
FIG. 4 Porter's Five Forces Analysis for Genomics and Proteomics Market
FIG. 5 Global Sample Preparation Kits Market for PCR, 2011-2019 (USD Million)
FIG. 6 Global Sample Preparation Kits Market for Mass Spectrometry, 2011-2019 (USD Million)
FIG. 7 Global Sample Preparation Kits Market for Chromatography, 2011-2019 (USD Million)
FIG. 8 Global Sample Preparation Kits Market for Electrophoresis, 2011-2019 (USD Million)
FIG. 9 Global Capillary Electrophoresis Market, 2011-2019 (USD Million)
FIG. 10 Global Gel Electrophoresis Market, 2011-2019 (USD Million)
FIG. 11 Global DNA Microarrays Market, 2011-2019 (USD Million)
FIG. 12 Global Protein and Peptide Microarrays Market, 2011-2019 (USD Million)
FIG. 13 Global Gas Chromatography Market, 2011-2019 (USD Million)
FIG. 14 Global Liquid Chromatography Market, 2011-2019 (USD Million)
FIG. 15 Global High Performance Liquid Chromatography Market, 2011-2019 (USD Million)
FIG. 16 Global Ultra High Performance Liquid Chromatography Market, 2011-2019 (USD Million)
FIG. 17 Global Tandem Mass Spectrometry Market, 2011-2019 (USD Million)
FIG. 18 Global Quadrupole Mass Spectrometry Market, 2011-2019 (USD Million)
FIG. 19 Global Fourier Transform Mass Spectrometry Market, 2011-2019 (USD Million)
FIG. 20 Global Time-Of-Flight Mass Spectrometry Market, 2011-2019 (USD Million)
FIG. 21 Global Other Mass Spectrometers Market, 2011-2019 (USD Million)
FIG. 22 Global Digital Thermal Cyclers Market, 2011-2019 (USD Million)
FIG. 23 Global Conventional or Traditional Thermal Cyclers Market, 2011-2019 (USD Million)
FIG. 24 Global Real-Time Thermal Cyclers Market, 2011-2019 (USD Million)
FIG. 25 Global Next Generation Sequencers Market, 2011-2019 (USD Million)
FIG. 26 North America Genomics and Proteomics Market, 2011 – 2019 (USD Million)
FIG. 27 Europe Genomics and Proteomics Market, 2011 – 2019 (USD Million)
FIG. 28 Asia-Pacific Genomics and Proteomics Market, 2011 – 2019 (USD Million)
FIG. 29 Rest of the World Genomics and Proteomics Market, 2011 – 2019 (USD Million)
FIG. 30 Global Genomics and Proteomics Market Share Analysis of Key Players, 2012 (%)
FIG. 31 Affymetrix: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 32 Agilent Technologies: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 33 Becton Dickinson: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 34 Bio-Rad: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 35 Bruker Corporation: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 36 Danaher Corporation: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 37 Illumina, Inc.: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 38 Life Technologies Corporation: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 39 Merck Millipore: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 40 Myriad Genetics, Inc.: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 41 Perkinelmer: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 42 Qiagen: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 43 Shimadzu Biotech: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 44 Sigma Aldrich: Annual Sales Revenue, USD Million, 2010 – 2012
FIG. 45 Thermo Scientific Fisher: Annual Sales Revenue, USD Million, 2010 – 2012

List of Tables

TABLE 1 Market Snapshot: Global Genomics and Proteomics Market
TABLE 2 Global Sample Preparation Kits Market, by Segments, 2011 - 2019 (USD Million)
TABLE 3 Global Purification Reagent Kits Market, by Segments, 2011 - 2019 (USD Million)
TABLE 4 Global Purification Kits Market, by Geography, 2011 - 2019 (USD Million)
TABLE 5 Global Electrophoresis Kits Market, by Geography, 2011 - 2019 (USD Million)
TABLE 6 Global Biochips and Microarrays Market, by Geography, 2011 - 2019 (USD Million)
TABLE 7 Global Chromatography Market, by Type, 2011 - 2019 (USD Million)
TABLE 8 Global Chromatography Market, by Geography, 2011 - 2019 (USD Million)
TABLE 9 Global Liquid Chromatography Market, by Type, 2011 - 2019 (USD Million)
TABLE 10 Global Mass Spectrometry Market, by Analyzers, 2011 - 2019 (USD Million)
TABLE 11 Global Thermal Cyclers Market, by Types, 2011 - 2019 (USD Million)
TABLE 12 Global Next Generation Sequencing Market, by Geography, 2011 - 2019 (USD Million)
TABLE 13 Global Genomics and Proteomics Market, by Geography, 2011 - 2019 (USD Million)
TABLE 14 North America Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
TABLE 15 Europe Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
TABLE 16 Asia-Pacific Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)
TABLE 17 ROW Genomics and Proteomics Market, by Segments, 2011 - 2019 (USD Million)

FEATURED COMPANIES

  • Affymetrix
  • Bio-Rad
  • Danaher Corporation
  • Merck Millipore
  • Perkinelmer
  • Shimadzu Biotech
  • MORE

The market is segmented into two major areas, namely, the genomics and proteomics reagent kits market and the genomics and proteomics analytical tools market. The reagent and research kits segment deals with the products used in sample preparation, purification and isolation, electrophoresis, lab-on-chip applications, and biochips or microarrays. In terms of analytical tools segment, the market is segmented into four major analytical tools, namely, chromatography, mass spectrometry, thermal cyclers for PCR applications and next generation sequencers. Till the beginning of 20th century the only available techniques for protein purification were precipitation, crystallization and filtration. Today, chromatography and gel electrophoresis are the most commonly used purification techniques - they isolate proteins on the basis of its characteristics such as solubility, size, charge and binding affinity.

Other technologies such as mass spectrometry, biochips, next-gen sequencers, and polymerase chain reaction techniques have empowered researchers to create very large quantities of data in short time. The next generation sequencing market is highly consolidated with very few market players due to extremely complicated technologies involved and the low target audience for the systems as of today. The cost of expensive next-gen sequencing systems may exceed into millions of dollars for installation, maintenance, reagents and output analysis. Most respondents have suggested sequencing as a service business rather than an investment for in-house research. Introduction of bench-top sequencer enabling ease of use to researchers is also expected to push the growth further. With progress in technology a genome can be sequenced for less than USD 1000, as compared to several billions that cost the Human Genome Project about two decades ago.

The market accounts for commercialized ready-to-use research kits to carry out various processes such as purification, electrophoresis, chromatography and polymerase chain reactions. Every step of sample preparation is critical as it is associated with the success of protein sequencing and expression. In order to simplify the process at each step vendors operating in this market offer a wide variety of protein sample preparation kits which are able to remove salts, denaturants, detergents and other buffers present in the crude mixtures easily and quickly.

The global market was estimated to be valued at USD 23.8 billion in 2012 and forecast to reach USD 52.3 billion by 2019 with a CAGR of 12.1% from 2013 to 2019. The global market is highly fragmented in molecular biology which constitutes most of research in biotechnology. North America continues to lead the world in terms of innovation in genomics and proteomics. Also, emerging applications in several segments of genomics and proteomics technologies have sprung up over the world and several countries are raising genomic and proteomics research centers in recent years. Market players such as Illumina, Sigma Aldrich, Thermo Fisher, Waters and Life Technologies who have been keen on expanding businesses overseas have continued sponsoring major seminars and conferences to raise awareness of analytical tools that can help researchers and countries identify and control pandemic and endemic diseases.

- Affymetrix
- Agilent Technologies
- Becton Dickinson & Company
- Bio-Rad
- Bruker Corporation
- Danaher Corporation
- Illumina, Inc
- Life Technologies Corporation
- Merck Millipore
- Myriad Genetics, Inc
- Perkinelmer
- Qiagen
- Shimadzu Biotech
- Sigma Aldrich Corporation
- Thermo Fisher Scientific

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos